TWC
WST icon

TD Waterhouse Canada’s West Pharmaceutical WST Stock Holding History

TD Waterhouse Canada’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.49M Sell
20,534
-1,418
-6% -$434K 0.02% 327
2026
Q1 		$5.54M Buy
21,952
+19,845
+942% +$4.94M 0.02% 364
2025
Q4 		$580K Sell
2,107
-17
-0.8% -$4.65K ﹤0.01% 665
2025
Q3 		$575K Buy
2,124
+49
+2% +$11.9K ﹤0.01% 649
2025
Q2 		$461K Buy
2,075
+41
+2% +$8.77K ﹤0.01% 673
2025
Q1 		$448K Sell
2,034
-207
-9% -$57K ﹤0.01% 652
2024
Q4 		$734K Buy
2,241
+347
+18% +$109K 0.01% 558
2024
Q3 		$567K Sell
1,894
-2,662
-58% -$815K ﹤0.01% 594
2024
Q2 		$1.48M Sell
4,556
-171
-4% -$60.4K 0.01% 419
2024
Q1 		$1.88M Buy
4,727
+461
+11% +$171K 0.01% 400
2023
Q4 		$1.49M Buy
4,266
+144
+3% +$51K 0.01% 366
2023
Q3 		$1.56M Buy
4,122
+1,535
+59% +$594K 0.02% 351
2023
Q2 		$1M Buy
2,587
+32
+1% +$11.4K 0.01% 412
2023
Q1 		$907K Buy
2,555
+1,393
+120% +$407K 0.01% 429
2022
Q4 		$274K Buy
1,162
+364
+46% +$86.3K ﹤0.01% 609
2022
Q3 		$205K Buy
798
+344
+76% +$105K ﹤0.01% 665
2022
Q2 		$141K Buy
454
+442
+3,683% +$144K ﹤0.01% 732
2022
Q1 		$5K Sell
12
-7,334
-100% -$2.87M ﹤0.01% 1449
2021
Q4 		$3.83M Buy
+7,346
New +$3.16M 0.04% 253

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TD Waterhouse Canada's WST Position: Q2 2026 in Review

TD Waterhouse Canada reduced its West Pharmaceutical (WST) stake by 6.5% in Q2 2026, selling an estimated $434K and leaving 20,534 shares worth $7.49M. The position accounts for 0.02% of the portfolio, ranked #327.

TD Waterhouse Canada first reported a position in WST in Q4 2021 and has held it in 19 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • TD Waterhouse Canada held 20,534 shares of West Pharmaceutical worth $7.49M as of Q2 2026.
  • TD Waterhouse Canada sold 1,418 West Pharmaceutical shares in Q2 2026, an estimated $434K.
  • West Pharmaceutical made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #327 holding.
  • TD Waterhouse Canada first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.